NCT05198427View on ClinicalTrials.gov

mTOR Inhibitors: the Lesions Induced by Papillomavirus for Transplant Patients.

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

February 14, 2022

Primary Completion Date

March 31, 2022

Study Completion Date

March 31, 2022

Conditions
Transplantation Organ
Interventions
OTHER

review of medical patient file

"The outcome measure is the evolution of HPV related lesions between :~* favourable evolution including partial or total regression~* unfavourable evolution including non-evolution or aggravation or recurrence."

Trial Locations (1)

69003

Hôpital Edouard Herriot, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER